IP Verse

Lek Pharmaceuticals D.d. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Lek Pharmaceuticals D.d.

Patent Number:
EP3886820
Title:
Capsule Formulations
Applicant:
CHEMOCENTRYX, INC.
Opposition Date:
Jan 12, 2024
Patent Number:
EP2451445
Title:
Process For Drying Of Bibw2992, Of Its Salts And Of Solid Pharmaceutical Formulations Comprising This Active Ingredient
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Dec 20, 2019
Patent Number:
EP3078667
Title:
Formulation Of Boronic Acid Compounds
Applicant:
THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Opposition Date:
Aug 14, 2019

Latest patents of Lek Pharmaceuticals D.d. opposed by its competitors

Patent:
EP2981520
Grant Date:
Mar 6, 2019
Title:
New Process For The Synthesis Of 1-(2-((2,4-Dimethylphenyl)Thio)Phenyl)Piperazine
Oppositions:
2
Patent:
EP2697251
Grant Date:
Feb 27, 2019
Title:
A Method For Controlling The Main Complex N-Glycan Structures And The Acidic Variants And Variability In Bioprocesses Producing Recombinant Proteins
Oppositions:
2
Patent:
EP2501799
Grant Date:
Jan 24, 2018
Title:
Production Of Glycoproteins With Low N-Glycolylneuraminic Acid (Neu5Gc) Content
Oppositions:
1

Competitors of Lek Pharmaceuticals D.d.

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

CHEMOCENTRYX, INC.

DIPHARMA FRANCIS S.R.L.

Want to track Lek Pharmaceuticals D.d.?

Feel free to send us a message here and we will get back to you